About the Event

Join Stephanie Morris, Director of Innovation and Translation for the Adelaide Intermediary Program as she hosts MTPConnect’s SA Insights Series for October.

Stephanie will facilitate a fire-side chat with Carina Biotech’s CEO, Dr Deborah Rathjen.

Carina Biotech recently raised AU$7.5m at first close of its current funding round with Tenmile the cornerstone investor. Carina Biotech, a pre-clinical company developing next generation CAR-T (chimeric antigen receptor T cell) technologies to fight cancer, will use the capital raise to complete its IND enabling studies and commence clinical studies for lead compound LGR5 CAR-T cell for patients with advanced colorectal cancer.

For Tenmile, the investment is one of the first for the new $250m venture fund backed by Twiggy Forrest’s Tattarang, kicking off its hunt for quality investment opportunities purely in Australian health technology companies.

Deborah will share insights into their respective entrepreneurial journeys so far, how the investment deal came about and what is in store for the next chapter of these exciting organisations.

This event will be followed by an opportunity to network over drinks and nibbles.

Who should attend:

Researchers, C-suite professionals in the HMI sector, investors, and entrepreneurs.

Researchers, clinicians, entrepreneurs, founders, MTP industry professionals, commercialisation professionals, members of the Adelaide ecosystem.

Bring a Plus 1 and WIN

Meet, greet, and take a seat at the SA Insights Series. Register for TWO today, meet-up at the SA Insights Series event and you are in the running to WIN a prize.

Bring a colleague or invite a person you have been trying to connect with.

We look forward to seeing you both at the event.

** please provide the name and email details for your guest during the registration process, so we can confirm numbers for catering**

Dr Deborah Rathjen bio:

Dr Rathjen is a highly experienced and respected leader in the biotechnology and pharmaceutical industries within Australia and internationally, and has achieved in excess of $800 million in deals including partnerships with Merck & Co., J&J, Abbott (AbbVie), Celgene, Nycomed (Takeda) and Merck KGaA. An immunologist by training, Dr Rathjen has extensive R&D experience in the areas of infection and immunity, inflammation, oncology and neuroscience, covering multiple treatment modalities.

As well as heading up Carina Biotech, Dr Rathjen is currently Executive Chair of US-headquartered Bioasis Technologies Inc. She is also a member of the Australian Medical Research Future Fund Advisory Board, the Million Minds Mental Health Research Mission Expert Panel, the Stem Cell Therapies Mission Expert Panel and the Federal Government’s Biomedical Translation Fund Committee.

More information: Carina Biotech

Carina Biotech

Carina is developing CAR-T therapy, (a new treatment option that uses a patient’s own immune system to fight their cancer) and other adoptive cell therapies to treat solid tumours. CAR-T therapies are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing.

Dr Steve Burnell bio:

Steve has considerable experience managing biotech and health technology investments and in building and leading global health technology businesses. He is passionate about the intersection of technology and biology and in driving equitable, sustainable healthcare.

More information: Tenmile

In the know:

Do you want to know more about the Adelaide Intermediary Program? Click the link and watch a presentation by Adelaide Intermediary Program Director Jo Close.

Stay connected to events, news and opportunities - Follow MTPConnect on EventBrite, click the follow button in the top right corner of the event listing.

Parking:

Please note nearest car parking is available at the Royal Adelaide Hospital, in the West End of Hindley Street and the Adelaide Convention Centre.

Further Information, visit the Eventbrite page. Brought to you by the Adelaide Intermediary Program.

---